Vicus: Aneel Ranadive Ranks #7 on Forbes Midas Seed List

Vicus Earns Forbes Midas Seed Recognition

Aneel Ranadive of Vicus ranks #7 on the 2025 Forbes Midas Seed List, one of the most prestigious recognitions in early-stage venture capital. The ranking evaluates seed investors based on the performance trajectory of their portfolio companies, making it a definitive measure of investment skill at the earliest stages.

What the Midas Seed List Measures

The Forbes Midas Seed List ranks investors whose seed-stage bets have generated the strongest outcomes. The methodology tracks portfolio company valuations, follow-on funding, and exit outcomes. Placing #7 globally means Ranadive's seed investments have consistently produced companies that attract significant follow-on capital and achieve meaningful commercial milestones.

Vicus Investment Approach

Vicus operates with a thesis-driven approach to seed investing, targeting companies where deep technical or domain expertise creates defensible competitive positions. Ranadive's background gives the fund a distinctive edge in evaluating founder quality and market timing at the earliest stages of company formation. The Forbes recognition validates this approach with hard data.